Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
TNXP · NASDAQ · Pharmaceutical Preparations
$2.38−0.17 (−6.67%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Tonix Pharmaceuticals Holding (TNXP) · oqro.io/stocks/TNXP · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
AQR Capital Management, LLC cut its TNXP stake below 5% (3.9%)SourceInsider trade · Traded Nov 11, 2026 · Filed Nov 12, 2026
CEO purchased ~$20K of TNXP shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 21, 2025
Director purchased ~$15K of TNXP shares in the open marketSourceInsider trade · Traded Aug 20, 2025 · Filed Aug 20, 2025
Director purchased ~$9K of TNXP shares in the open marketSourceInsider trade · Traded May 15, 2025 · Filed May 15, 2025
CEO purchased ~$86K of TNXP shares in the open marketSource